PFF Webinar Library

ILD Day graphic

Progressive Pulmonary Fibrosis: What Patients Need to Know

Wed, Sep 14, 2022
Dr. Podolanczuk is a nationally and internationally recognized expert in interstitial lung disease. She received her undergraduate degree in Neuroscience from Brown University. She earned her MD from NYU School of Medicine. She completed residency in Internal Medicine and fellowship in Pulmonary and Critical Care Medicine at Columbia University. She received additional training in advanced pulmonary diseases at Columbia University. She also earned a Masters of Science in Patient-Oriented Research from Columbia’s Mailman School of Public Health, with a focus on epidemiology and biostatistics.
 
Dr. Podolanczuk is an NIH-funded investigator studying novel risk factors for pulmonary fibrosis in humans. Her research program focuses on understanding early or subclinical interstitial lung disease, characterizing imaging and blood biomarkers of pulmonary fibrosis, the role of environmental exposures, and the connection between cardiovascular disease and pulmonary fibrosis. She is also a site investigator for several multi-center clinical trials of new therapies for pulmonary fibrosis.

SPONSORED WITH THE GENEROUS SUPPORT OF

Boehringer-Ingelheim

Genentech_RGB2
 

Recent Webinars

  • Aug
    28
    2024

    EXPOSED: The Impact of Inhaled Exposures on PF

    View Webinar
  • pulmonary-fibrosis-lungs
    Jul
    24
    2024

    Lung Transplant: How to prepare

    View Webinar
  • Jun
    26
    2024

    Medications for PF

    View Webinar
  • May
    29
    2024

    Pulmonary Fibrosis and Pulmonary Rehabilitation: Exercise, Education, and Empowerment

    View Webinar